On Monday, SELLAS Life Sciences Group Inc (NASDAQ: SLS) was 4.60% up from the session before settling in for the closing price of $1.74. A 52-week range for SLS has been $0.77 – $2.48.
A company in the Healthcare sector has jumped its sales by 45.94% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 47.00%. With a float of $142.00 million, this company’s outstanding shares have now reached $142.44 million.
SELLAS Life Sciences Group Inc (SLS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward SELLAS Life Sciences Group Inc stocks. The insider ownership of SELLAS Life Sciences Group Inc is 0.31%, while institutional ownership is 23.22%. The most recent insider transaction that took place on Nov 19 ’25, was worth 100,806. In this transaction Director of this company bought 63,400 shares at a rate of $1.59, taking the stock ownership to the 104,400 shares. Before that another transaction happened on Jun 12 ’25, when Company’s Director bought 10,000 for $1.48, making the entire transaction worth $14,800. This insider now owns 20,400 shares in total.
SELLAS Life Sciences Group Inc (SLS) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.08 earnings per share (EPS) during the time that was better than consensus figure (set at -0.11) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.20% during the next five years compared to 45.94% growth over the previous five years of trading.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Trading Performance Indicators
You can see what SELLAS Life Sciences Group Inc (SLS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.28.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.29, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of SELLAS Life Sciences Group Inc (SLS)
Let’s dig in a bit further. During the last 5-days, its volume was 6.75 million. That was better than the volume of 2.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 75.36%.
During the past 100 days, SELLAS Life Sciences Group Inc’s (SLS) raw stochastic average was set at 39.45%, which indicates a significant decrease from 70.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1478 in the past 14 days, which was higher than the 0.1264 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.7411, while its 200-day Moving Average is $1.6170. However, in the short run, SELLAS Life Sciences Group Inc’s stock first resistance to watch stands at $1.9633. Second resistance stands at $2.1067. The third major resistance level sits at $2.2133. If the price goes on to break the first support level at $1.7133, it is likely to go to the next support level at $1.6067. Assuming the price breaks the second support level, the third support level stands at $1.4633.
SELLAS Life Sciences Group Inc (NASDAQ: SLS) Key Stats
There are 142,442K outstanding shares of the company, which has a market capitalization of 259.25 million. As of now, sales total 0 K while income totals -30,880 K. Its latest quarter income was 0 K while its last quarter net income were -6,790 K.
